Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9IJB

Crystal structure and function analysis of a highly potential drug target 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis

Summary for 9IJB
Entry DOI10.2210/pdb9ijb/pdb
Descriptor6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating (2 entities in total)
Functional Keywordstecramer, dehydrogenase enzyme, nad binding, pentose phosphate pathway, hydrolase
Biological sourceMycobacterium tuberculosis
Total number of polymer chains4
Total formula weight145600.30
Authors
Wang, Y.Z.,Ren, X.Q.,Li, T.,Zhang, R.D. (deposition date: 2024-06-22, release date: 2024-07-03, Last modification date: 2024-08-07)
Primary citationWang, Y.,Ren, X.,Li, T.,Su, D.,Zhang, R.
Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis.
Biochem.Biophys.Res.Commun., 731:150390-150390, 2024
Cited by
PubMed Abstract: 6-phosphogluconate dehydrogenase (6PGDH) is an essential enzyme in energy metabolism and redox reactions, and represents a potential drug target for the development of therapies targeting trypanosomes, plasmodium, or other pathogens. Tuberculosis, caused by Mycobacterium tuberculosis, is a contagious disease that severely affects human health, with approximately one-third of the world's population infected. However, the protein structure, exact oligomeric state, and catalytic mechanism of 6PGDH in Mycobacterium tuberculosis (Mt6PGDH) have remained largely unknown. In this study, we successfully purified and determined the structure of Mt6PGDH, revealing its function as a tetramer in both solution and crystal states. Through structural comparisons, we clarified the tetramer formation mechanism and the oligomeric organization of short-chain 6PGDHs. Additionally, we identified key residues for coenzyme recognition and catalytic activity. This work not only deepens our understanding of the enzymatic function of Mt6PGDH but also lays a foundation for the development of drugs targeting this enzyme.
PubMed: 39024980
DOI: 10.1016/j.bbrc.2024.150390
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7404051296 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon